These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 11168952

  • 1. Progression of diabetic nephropathy.
    Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.
    Kidney Int; 2001 Feb; 59(2):702-9. PubMed ID: 11168952
    [Abstract] [Full Text] [Related]

  • 2. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH.
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.
    J Nephrol; 2001 Jul; 14(6):461-71. PubMed ID: 11783602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Progression of nephropathy in type 2 diabetic patients.
    Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.
    Kidney Int; 2004 Oct; 66(4):1596-605. PubMed ID: 15458456
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
    Parving HH, Rossing P, Hommel E, Smidt UM.
    Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Smoking and progression of diabetic nephropathy in type 1 diabetes.
    Hovind P, Rossing P, Tarnow L, Parving HH.
    Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
    [Abstract] [Full Text] [Related]

  • 10. Course of glomerular filtration rate in albuminuric type 2 diabetic patients with or without diabetic glomerulopathy.
    Christensen PK, Gall MA, Parving HH.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B14-20. PubMed ID: 10860186
    [Abstract] [Full Text] [Related]

  • 11. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
    Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH.
    Diabetologia; 2004 Nov; 47(11):1936-9. PubMed ID: 15551047
    [Abstract] [Full Text] [Related]

  • 12. PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.
    Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O.
    Nephrol Dial Transplant; 2002 Aug; 17(8):1408-12. PubMed ID: 12147787
    [Abstract] [Full Text] [Related]

  • 13. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
    Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH.
    Diabetes Care; 2001 Nov; 24(11):1972-7. PubMed ID: 11679467
    [Abstract] [Full Text] [Related]

  • 14. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA, Nielsen FS, Smidt UM, Parving HH.
    Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
    [Abstract] [Full Text] [Related]

  • 15. Constant glomerular filtration rate in diabetic nephropathy. Correlation to blood pressure and blood glucose control.
    Nyberg G, Blohmé G, Nordén G.
    Acta Med Scand; 1986 Oct; 219(1):67-72. PubMed ID: 3082107
    [Abstract] [Full Text] [Related]

  • 16. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Diabetologia; 1994 May; 37(5):511-6. PubMed ID: 8056190
    [Abstract] [Full Text] [Related]

  • 17. Renal function and structure in albuminuric type 2 diabetic patients without retinopathy.
    Christensen PK, Larsen S, Horn T, Olsen S, Parving HH.
    Nephrol Dial Transplant; 2001 Dec; 16(12):2337-47. PubMed ID: 11733625
    [Abstract] [Full Text] [Related]

  • 18. Rate of decline of GFR and progression of vascular disease in type 2 diabetic patients with diabetic or vascular nephropathy during the last three years before starting dialysis therapy.
    Biesenbach G, Schmekal B, Pieringer H, Janko O.
    Kidney Blood Press Res; 2006 Dec; 29(5):267-72. PubMed ID: 17035711
    [Abstract] [Full Text] [Related]

  • 19. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [Abstract] [Full Text] [Related]

  • 20. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P, Tarnow L, Oestergaard PB, Parving HH.
    Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.